View of EXPANDING THERAPEUTIC HORIZONS OF GLP-1 RECEPTOR AGONISTS: FROM METABOLIC REGULATION TO NEUROPROTECTION IN ALZHEIMER’S DISEASE AND ADDICTION DISORDERS – A COMPREHENSIVE REVIEW

Return to Article Details EXPANDING THERAPEUTIC HORIZONS OF GLP-1 RECEPTOR AGONISTS: FROM METABOLIC REGULATION TO NEUROPROTECTION IN ALZHEIMER’S DISEASE AND ADDICTION DISORDERS – A COMPREHENSIVE REVIEW Download Download PDF